July 2024 in “Journal of the American Academy of Dermatology” Botulinum toxin may help treat male pattern baldness.
26 citations
,
January 1992 in “Carcinogenesis” TPA strongly increases ODC activity in certain skin cells, potentially aiding tumor growth.
1 citations
,
March 2024 in “International Journal of Dermatology” CO2 laser-associated PDT effectively treated therapy-resistant folliculitis decalvans.
5 citations
,
February 2021 in “Gels” HYDRO DELUXE BIO hyaluronic acid hydrogel is compatible with skin cells, may reduce inflammation, promote blood vessel growth, and protect against oxidative stress, suggesting it could help revitalize hair follicles.
Recombinant human growth hormone helps burn wounds heal faster by increasing blood vessel growth.
3 citations
,
August 2024 in “Journal of Cosmetic Dermatology” Combining laser therapy with hair extraction improves eyebrow scar treatment.
91 citations
,
July 2010 in “Tissue Engineering Part A” Low-oxygen conditions and ECM degradation products increase the healing abilities of perivascular stem cells.
July 2025 in “Russian Journal of Clinical Dermatology and Venereology” Botulinum toxin is not proven effective for treating hair loss.
6 citations
,
May 2023 in “Drugs” Baricitinib helps regrow hair in adults with severe alopecia better than a placebo and is approved for treatment, but long-term effects are still unknown.
August 2025 in “Systematic Reviews” Photobiomodulation may improve certain health conditions, but more high-quality research is needed.
5 citations
,
May 2022 in “Biomedicines” Botryococcus terribilis and its compounds may promote hair growth and improve hair health.
14 citations
,
January 2025 in “Journal of Dermatological Treatment” Baricitinib is effective and safe for treating severe alopecia areata, promoting significant hair regrowth.
1 citations
,
August 2024 in “Lasers in Surgery and Medicine” Calcium hydroxylapatite can be successfully integrated into healing skin and stimulates collagen.
156 citations
,
October 1996 in “Science of The Total Environment” Tributyltin exposure causes sex changes, sterilization, and decline in the snail Ocinebrina aciculata, risking its extinction.
Hair intradermotherapy effectively treats hair loss and boosts self-esteem.
August 2023 in “Journal of Cosmetic Dermatology” Higher concentration of botulinum toxin A is safe and effective for treating hair loss in men and women.
November 2023 in “ACS Applied Polymer Materials” The new method extracts keratin from hair faster and better, and the resulting product improves blood clotting and wound healing, with potential for personalized treatments.
November 2025 in “Advanced Science” A new nanozyme using EGCG and L-arginine boosts hair growth by safely increasing beneficial oxidative stress.
39 citations
,
January 2006 in “Journal of Cosmetic and Laser Therapy” Pneumatic Skin Flattening (PSF) significantly reduces pain during laser and IPL hair removal.
May 2026 in “International Journal of Cosmetic Science” Ozonated water damages hair structure and proteins.
1 citations
,
January 2022 in “Burns” Taurine and apocynin together improve burn healing, especially later in recovery.
13 citations
,
February 2024 in “Clinical Cosmetic and Investigational Dermatology” Polynucleotides HPT improves Asian skin tone, firmness, and glow safely.
January 2025 in “Dermatologic Therapy” CO₂ laser therapy improves skin and hair growth in localized scleroderma without severe side effects.
January 2024 in “Theranostics” Exosomes from special stem cells help treat ulcerative colitis by reducing inflammation and stress.
60 citations
,
November 2020 in “International Journal of Medical Sciences” NIR light therapy may effectively treat eye diseases and improve brain function without side effects.
September 2024 in “Journal of the American Academy of Dermatology” Baricitinib helps long-term hair regrowth in severe alopecia areata patients.
May 2026 in “Journal of Clinical Oncology” This study at the Royal Marsden Hospital examined the long-term effects of Brentuximab Vedotin (BV)-associated alopecia in 13 patients with Hodgkin’s Lymphoma. All patients experienced generalised hair loss, with 38.5% reporting persistent abnormal regrowth over two years post-treatment. The study highlighted significant psychosocial impacts, including reduced self-confidence and emotional distress, with 36% of patients struggling to accept changes in appearance. Despite BV's therapeutic benefits, the study underscores the need for further research into BV-associated alopecia to improve prevention and support for affected patients.
October 2023 in “The Open Dermatology Journal” Baricitinib is effective for severe alopecia areata with manageable side effects, mainly upper respiratory infections.
April 2025 in “Pharmaceutics” Oil A formulation with Baricitinib shows promise for treating alopecia areata by promoting hair growth.